Last 12 months
Inside the activity.
7 purchase rows · 0 sale rows
Disclosed non-derivative P/S rows, by transaction month. Includes amendments and private transactions.Monthly counts
| Month | Purchases | Sales |
|---|---|---|
| Nov 2025 | 1 | 0 |
| Dec 2025 | 1 | 0 |
| Jan 2026 | 0 | 0 |
| Feb 2026 | 2 | 0 |
| Mar 2026 | 1 | 0 |
| Apr 2026 | 0 | 0 |
| May 2026 | 2 | 0 |
| Jun 2026 | 0 | 0 |
| Jul 2026 | 0 | 0 |
| Aug 2026 | 0 | 0 |
| Sep 2026 | 0 | 0 |
| Oct 2026 | 0 | 0 |
Latest available
Insider transactions
Purchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”
The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.
| Transaction date | Owner / reported role | Activity / security | Shares / units | Reported price | Reported value | Details |
|---|---|---|---|---|---|---|
| January 31, 2023 Filed Feb 3, 2023 01:25 UTC |
Brophy GerardEVP, Biopharma Production
|
GrantCommon Stock | 38,737 | $0.00 | $0.00 |
DisclosureSEC source: 0001722482-23-000023 · wf-form4_167538752663268.xml · nonDerivative · entry 1 Brophy Gerard · CIK 0001776107 · EVP, Biopharma Production 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 128,945 F1 · kind: Reflects performance-based restricted stock units previously granted to the Reporting Person, the performance of which was certified on January 31, 2023. Each performance-based restricted stock unit represents a contingent right to receive one share of Common Stock of the Issuer. Read SEC document |
| January 31, 2023 Filed Feb 3, 2023 01:25 UTC |
Miller JustinEVP & General Counsel
|
Tax withholdingCommon Stock | 7,942 | $23.90 | $189,813.80 |
DisclosureSEC source: 0001722482-23-000022 · wf-form4_167538750694804.xml · nonDerivative · entry 2 Miller Justin · CIK 0001776122 · EVP & General Counsel 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 98,842 F3 · kind: Reflects shares of Common Stock withheld to cover the Reporting Person's tax liability in connection with the vesting and settlement of the performance-based restricted stock units described herein. Read SEC document |
| January 31, 2023 Filed Feb 3, 2023 01:25 UTC |
Miller JustinEVP & General Counsel
|
GrantCommon Stock | 26,818 | $0.00 | $0.00 |
DisclosureSEC source: 0001722482-23-000022 · wf-form4_167538750694804.xml · nonDerivative · entry 1 Miller Justin · CIK 0001776122 · EVP & General Counsel 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 106,784 F1 · kind: Reflects performance-based restricted stock units previously granted to the Reporting Person, the performance of which was certified on January 31, 2023. Each performance-based restricted stock unit represents a contingent right to receive one share of Common Stock of the Issuer. F2 · balance_after: Includes 654 shares acquired under the Avantor Employee Stock Purchase Plan. Read SEC document |
| January 31, 2023 Filed Feb 3, 2023 01:24 UTC |
Vanderhaegen FredericEVP, Americas & Europe
|
Tax withholdingCommon Stock | 2,515 | $23.90 | $60,108.50 |
DisclosureSEC source: 0001722482-23-000020 · wf-form4_167538747070888.xml · nonDerivative · entry 2 Vanderhaegen Frederic · CIK 0001776162 · EVP, Americas & Europe 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 168,547 F2 · kind: Reflects shares of Common Stock withheld to cover the Reporting Person's tax liability in connection with the vesting and settlement of the performance-based restricted stock units described herein. Read SEC document |
| January 31, 2023 Filed Feb 3, 2023 01:24 UTC |
Vanderhaegen FredericEVP, Americas & Europe
|
GrantCommon Stock | 44,669 | $0.00 | $0.00 |
DisclosureSEC source: 0001722482-23-000020 · wf-form4_167538747070888.xml · nonDerivative · entry 1 Vanderhaegen Frederic · CIK 0001776162 · EVP, Americas & Europe 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 171,062 F1 · kind: Reflects performance-based restricted stock units previously granted to the Reporting Person, the performance of which was certified on January 31, 2023. Each performance-based restricted stock unit represents a contingent right to receive one share of Common Stock of the Issuer. Read SEC document |
| January 02, 2023 Filed Jan 4, 2023 21:57 UTC |
Szlosek Thomas AEVP & CFO
|
Tax withholdingCommon Stock | 8,313 | $21.09 | $175,321.17 |
DisclosureSEC source: 0001722482-23-000007 · wf-form4_167286943436153.xml · nonDerivative · entry 1 Szlosek Thomas A · CIK 0001293167 · EVP & CFO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 109,395 F1 · kind: Represents the number of shares withheld by the Issuer to cover tax withholding obligations in connection with the vesting of RSUs. Read SEC document |
| January 02, 2023 Filed Jan 4, 2023 21:58 UTC |
Brophy GerardEVP, Biopharma Production
|
Tax withholdingCommon Stock | 6,727 | $21.09 | $141,872.43 |
DisclosureSEC source: 0001722482-23-000008 · wf-form4_167286946695888.xml · nonDerivative · entry 1 Brophy Gerard · CIK 0001776107 · EVP, Biopharma Production 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 90,208 F1 · kind: Represents the number of shares withheld by the Issuer to cover tax withholding obligations in connection with the vesting of RSUs. Read SEC document |
| January 02, 2023 Filed Jan 4, 2023 21:57 UTC |
Vanderhaegen FredericEVP, Americas & Europe
|
Tax withholdingCommon Stock | 1,017 | $21.09 | $21,448.53 |
DisclosureSEC source: 0001722482-23-000006 · wf-form4_167286940711017.xml · nonDerivative · entry 1 Vanderhaegen Frederic · CIK 0001776162 · EVP, Americas & Europe 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 126,363 F1 · kind: Represents the number of shares withheld by the Issuer to cover tax withholding obligations in connection with the vesting of RSUs. F2 · balance_after: Includes 616 shares acquired under the Avantor Employee Stock Purchase Plan Read SEC document |
| December 31, 2022 Filed Jan 4, 2023 21:59 UTC |
Henson MeghanEVP, Chief HR Officer
|
Tax withholdingCommon Stock | 1,790 | $21.09 | $37,751.10 |
DisclosureSEC source: 0001722482-23-000010 · wf-form4_167286954485932.xml · nonDerivative · entry 1 Henson Meghan · CIK 0001839411 · EVP, Chief HR Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 29,615 F1 · kind: Represents the number of shares withheld by the Issuer to cover tax withholding obligations in connection with the vesting of RSUs. Read SEC document |
| December 31, 2022 Filed Jan 4, 2023 21:59 UTC |
Lewis SheriEVP, Global Ops & Supply Chain
|
Tax withholdingCommon Stock | 6,075 | $21.09 | $128,121.75 |
DisclosureSEC source: 0001722482-23-000009 · wf-form4_167286949651700.xml · nonDerivative · entry 1 Lewis Sheri · CIK 0001839410 · EVP, Global Ops & Supply Chain 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 65,373 F1 · kind: Represents the number of shares withheld by the Issuer to cover tax withholding obligations in connection with the vesting of RSUs. Read SEC document |
| November 16, 2022 Filed Nov 17, 2022 21:42 UTC |
Szlosek Thomas AEVP & CFO
|
PurchaseCommon Stock | 12,500 | $20.71 | $258,850.00 |
DisclosureSEC source: 0001722482-22-000190 · wf-form4_166872135834876.xml · nonDerivative · entry 1 Szlosek Thomas A · CIK 0001293167 · EVP & CFO 10b5-1 filing: Not disclosed Ownership: Indirect · By Trust Disclosed balance after: 35,668 F1 · price: The price reported in Column 4 is a weighted average price. These shares were purchased in multiple transactions ranging from $20.695 to $20.710, inclusive. The Reporting Person undertakes to provide the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each price within the range set forth above. F2 · balance_after: Reflects a transfer by the Reporting Person of 23,168 shares into a Revocable Living Trust of which the Reporting Person is the sole beneficiary and sole trustee. Read SEC document |
| November 16, 2022 Filed Nov 17, 2022 21:42 UTC |
Stubblefield MichaelDirector · CEO
|
PurchaseCommon Stock | 15,000 | $20.95 | $314,250.00 |
DisclosureSEC source: 0001722482-22-000189 · wf-form4_166872133721080.xml · nonDerivative · entry 1 Stubblefield Michael · CIK 0001776153 · Director · CEO 10b5-1 filing: Not disclosed Ownership: Indirect · See Footnote Disclosed balance after: 429,500 F1 · price: The price reported in Column 4 is a weighted average price. These shares were purchased in multiple transactions ranging from $20.935 to $20.96, inclusive. The Reporting Person undertakes to provide the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each price within the range set forth above. F2 · ownership.nature: Reflects securities held by a trust for the benefit of the Reporting Person's family, of which the spouse of the Reporting Person is the trustee. The Reporting Person disclaims beneficial ownership of the securities held by the trust, except to the extent of his pecuniary interest therein. Read SEC document |
| May 23, 2022 Filed May 23, 2022 20:45 UTC |
Vanderhaegen FredericEVP, Americas & Europe
|
SaleCommon Stock | 39,000 | $31.61 | $1,232,790.00 |
DisclosureSEC source: 0001722482-22-000146 · wf-form4_165333871258355.xml · nonDerivative · entry 1 Vanderhaegen Frederic · CIK 0001776162 · EVP, Americas & Europe 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 126,764 F1 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions ranging from $31.57 to $31.68, inclusive. The Reporting Person undertakes to provide the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each price within the range set forth above. Read SEC document |
| May 20, 2022 Filed May 23, 2022 20:46 UTC |
Brophy GerardEVP, Biopharma Production
|
SaleCommon Stock | 19,603 | $31.27 | $612,985.81 |
DisclosureSEC source: 0001722482-22-000147 · wf-form4_165333876779150.xml · nonDerivative · entry 1 Brophy Gerard · CIK 0001776107 · EVP, Biopharma Production 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 96,935 F1 · kind: The sale reported on this Form 4 was effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person. F2 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions ranging from $31.14 to $31.39, inclusive. The Reporting Person undertakes to provide the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each price within the range set forth above. Read SEC document |
| May 17, 2022 Filed May 19, 2022 16:14 UTC |
Couturier ChristopheEVP, AMEA
|
Tax withholdingCommon Stock | 16,212 | $31.33 | $507,921.96 |
DisclosureSEC source: 0001722482-22-000141 · wf-form4_165299123019551.xml · nonDerivative · entry 1 Couturier Christophe · CIK 0001684076 · EVP, AMEA 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 98,348 F1 · kind: Represents the number of shares withheld by the Issuer to cover tax withholding obligations in connection with the vesting of RSUs. Read SEC document |
| May 17, 2022 Filed May 19, 2022 20:14 UTC |
Szlosek Thomas AEVP & CFO
|
Tax withholdingCommon Stock | 23,261 | $31.33 | $728,767.13 |
DisclosureSEC source: 0001722482-22-000142 · wf-form4_165299124776778.xml · nonDerivative · entry 1 Szlosek Thomas A · CIK 0001293167 · EVP & CFO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 140,260 F1 · kind: Represents the number of shares withheld by the Issuer to cover tax withholding obligations in connection with the vesting of RSUs. F2 · balance_after: Reflects a transfer by the Reporting Person of 89,225 shares into a grantor retained annuity trust on May 13, 2022. Read SEC document |
| May 17, 2022 Filed May 19, 2022 20:15 UTC |
Vanderhaegen FredericEVP, Americas & Europe
|
Tax withholdingCommon Stock | 2,210 | $31.33 | $69,239.30 |
DisclosureSEC source: 0001722482-22-000145 · wf-form4_165299129752171.xml · nonDerivative · entry 1 Vanderhaegen Frederic · CIK 0001776162 · EVP, Americas & Europe 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 165,764 F1 · kind: Represents the number of shares withheld by the Issuer to cover tax withholding obligations in connection with the vesting of RSUs. Read SEC document |
| May 17, 2022 Filed May 19, 2022 20:14 UTC |
Eck Steven WSVP & Chief Accounting Officer
|
Tax withholdingCommon Stock | 573 | $31.33 | $17,952.09 |
DisclosureSEC source: 0001722482-22-000144 · wf-form4_165299128007023.xml · nonDerivative · entry 1 Eck Steven W · CIK 0001748813 · SVP & Chief Accounting Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 17,747 F1 · kind: Represents the number of shares withheld by the Issuer to cover tax withholding obligations in connection with the vesting of RSUs. Read SEC document |
| May 17, 2022 Filed May 19, 2022 20:14 UTC |
Miller JustinEVP & General Counsel
|
Tax withholdingCommon Stock | 12,935 | $31.33 | $405,253.55 |
DisclosureSEC source: 0001722482-22-000143 · wf-form4_165299126439078.xml · nonDerivative · entry 1 Miller Justin · CIK 0001776122 · EVP & General Counsel 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 79,312 F1 · kind: Represents the number of shares withheld by the Issuer to cover tax withholding obligations in connection with the vesting of RSUs. Read SEC document |
| May 17, 2022 Filed May 19, 2022 20:13 UTC |
Stubblefield MichaelDirector · President and CEO
|
Tax withholdingCommon Stock | 108,700 | $31.33 | $3,405,571.00 |
DisclosureSEC source: 0001722482-22-000140 · wf-form4_165299120074100.xml · nonDerivative · entry 1 Stubblefield Michael · CIK 0001776153 · Director · President and CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,189,841 F1 · kind: Represents the number of shares withheld by the Issuer to cover tax withholding obligations in connection with the vesting of RSUs. Read SEC document |
| May 17, 2022 Filed May 19, 2022 20:13 UTC |
Brophy GerardEVP, Biopharma Production
|
Tax withholdingCommon Stock | 19,683 | $31.33 | $616,668.39 |
DisclosureSEC source: 0001722482-22-000139 · wf-form4_165299118031958.xml · nonDerivative · entry 1 Brophy Gerard · CIK 0001776107 · EVP, Biopharma Production 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 116,538 F1 · kind: Represents the number of shares withheld by the Issuer to cover tax withholding obligations in connection with the vesting of RSUs. Read SEC document |
| May 12, 2022 Filed May 16, 2022 22:11 UTC |
SUMME GREGORY LDirector
|
GrantCommon Stock | 6,693 | $0.00 | $0.00 |
DisclosureSEC source: 0001722482-22-000122 · wf-form4_165273905532434.xml · nonDerivative · entry 1 SUMME GREGORY L · CIK 0001143422 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 22,726 F1 · kind: Reflects a grant of restricted stock units that vests on February May 12, 2023. Read SEC document |
| May 12, 2022 Filed May 16, 2022 18:14 UTC |
Carethers JohnDirector
|
GrantCommon Stock | 6,693 | $0.00 | $0.00 |
DisclosureSEC source: 0001722482-22-000126 · wf-form4_165273926039035.xml · nonDerivative · entry 1 Carethers John · CIK 0001874604 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 10,473 F1 · kind: Reflects a grant of restricted stock units that vests on May 12, 2023. Read SEC document |
| May 12, 2022 Filed May 16, 2022 18:12 UTC |
Kang LanDirector
|
GrantCommon Stock | 6,693 | $0.00 | $0.00 |
DisclosureSEC source: 0001722482-22-000123 · wf-form4_165273912074678.xml · nonDerivative · entry 1 Kang Lan · CIK 0001863043 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 11,930 F1 · kind: Reflects a grant of restricted stock units that vests on May 12, 2023. Read SEC document |
| May 12, 2022 Filed May 16, 2022 18:13 UTC |
Peacock Jonathan MDirector
|
GrantCommon Stock | 6,693 | $0.00 | $0.00 |
DisclosureSEC source: 0001722482-22-000124 · wf-form4_165273915693341.xml · nonDerivative · entry 1 Peacock Jonathan M · CIK 0001500241 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 176,339 F1 · kind: Reflects a grant of restricted stock units that vests on May 12, 2023. Read SEC document |
| May 12, 2022 Filed May 16, 2022 22:15 UTC |
Massaro Joseph RDirector
|
GrantCommon Stock | 6,693 | $0.00 | $0.00 |
DisclosureSEC source: 0001722482-22-000127 · wf-form4_165273929211258.xml · nonDerivative · entry 1 Massaro Joseph R · CIK 0001380017 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 8,653 F1 · kind: Reflects a grant of restricted stock units that vests May 12, 2023. Read SEC document |
| May 12, 2022 Filed May 16, 2022 22:17 UTC |
SEVERINO MICHAELDirector
|
GrantCommon Stock | 6,693 | $0.00 | $0.00 |
DisclosureSEC source: 0001722482-22-000131 · wf-form4_165273941969121.xml · nonDerivative · entry 1 SEVERINO MICHAEL · CIK 0001609447 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 25,166 F1 · kind: Reflects a grant of restricted stock units that vests on May 12, 2023. Read SEC document |
| May 12, 2022 Filed May 16, 2022 18:16 UTC |
Holt Matthew S.Director
|
GrantCommon Stock | 6,693 | $0.00 | $0.00 |
DisclosureSEC source: 0001722482-22-000129 · wf-form4_165273934225293.xml · nonDerivative · entry 1 Holt Matthew S. · CIK 0001631836 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 7,908 F1 · kind: Reflects a grant of restricted stock units that vests on May 12, 2023. Read SEC document |
| May 12, 2022 Filed May 16, 2022 22:16 UTC |
Shaw ChristiDirector
|
GrantCommon Stock | 6,693 | $0.00 | $0.00 |
DisclosureSEC source: 0001722482-22-000130 · wf-form4_165273939485666.xml · nonDerivative · entry 1 Shaw Christi · CIK 0001702473 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 26,463 F1 · kind: Reflects a grant of restricted stock units that vests on May 12, 2023. Read SEC document |
| May 12, 2022 Filed May 16, 2022 22:15 UTC |
Murthy MalaDirector
|
GrantCommon Stock | 6,693 | $0.00 | $0.00 |
DisclosureSEC source: 0001722482-22-000128 · wf-form4_165273931969589.xml · nonDerivative · entry 1 Murthy Mala · CIK 0001780955 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 8,824 F1 · kind: Reflects a grant of restricted stock units that vests on May 12, 2023. Read SEC document |
| May 12, 2022 Filed May 16, 2022 22:14 UTC |
Andres JuanDirector
|
GrantCommon Stock | 6,693 | $0.00 | $0.00 |
DisclosureSEC source: 0001722482-22-000125 · wf-form4_165273923846993.xml · nonDerivative · entry 1 Andres Juan · CIK 0001760670 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 30,095 F1 · kind: Reflects a grant of restricted stock units that vests on May 12, 2023. Read SEC document |
| May 04, 2022 Filed May 6, 2022 20:55 UTC |
Stubblefield MichaelDirector · President and CEO
|
GiftCommon Stock | 14,500 | $0.00 | $0.00 |
DisclosureSEC source: 0001722482-22-000116 · wf-form4_165187050078674.xml · nonDerivative · entry 2 Stubblefield Michael · CIK 0001776153 · Director · President and CEO 10b5-1 filing: Not disclosed Ownership: Indirect · See Footnote Disclosed balance after: 414,500 F1 · kind: Reflects a gift of shares by the Reporting Person to a trust for the benefit of the Reporting Person's family, of which the spouse of the Reporting Person is the trustee. F2 · ownership.nature: Reflects securities held by a trust for the benefit of the Reporting Person's family, of which the spouse of the Reporting Person is the trustee. The Reporting Person disclaims beneficial ownership of the securities held by the trust, except to the extent of his pecuniary interest therein. Read SEC document |
| May 04, 2022 Filed May 6, 2022 20:55 UTC |
Stubblefield MichaelDirector · President and CEO
|
GiftCommon Stock | 14,500 | $0.00 | $0.00 |
DisclosureSEC source: 0001722482-22-000116 · wf-form4_165187050078674.xml · nonDerivative · entry 1 Stubblefield Michael · CIK 0001776153 · Director · President and CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,298,541 F1 · kind: Reflects a gift of shares by the Reporting Person to a trust for the benefit of the Reporting Person's family, of which the spouse of the Reporting Person is the trustee. Read SEC document |
| April 05, 2022 Filed Apr 7, 2022 17:47 UTC |
Couturier ChristopheEVP, AMEA
|
Tax withholdingCommon Stock | 568 | $31.62 | $17,960.16 |
DisclosureSEC source: 0001722482-22-000092 · wf-form4_164936805805976.xml · nonDerivative · entry 1 Couturier Christophe · CIK 0001684076 · EVP, AMEA 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 114,560 F1 · kind: Represents the number of shares withheld by the Issuer to cover tax withholding obligations in connection with the vesting of RSUs. Read SEC document |
| April 01, 2022 Filed Apr 5, 2022 16:58 UTC |
GUPTA RAJIVDirector
|
GrantCommon Stock | 1,215 | $0.00 | $0.00 |
DisclosureSEC source: 0001722482-22-000084 · wf-form4_164919227643392.xml · nonDerivative · entry 1 GUPTA RAJIV · CIK 0001068731 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 780,562 F1 · kind: Reflects a grant of restricted stock units that vests on May 11, 2022. Read SEC document |
| April 01, 2022 Filed Apr 5, 2022 20:57 UTC |
SUMME GREGORY LDirector
|
GrantCommon Stock | 1,215 | $0.00 | $0.00 |
DisclosureSEC source: 0001722482-22-000082 · wf-form4_164919224098877.xml · nonDerivative · entry 1 SUMME GREGORY L · CIK 0001143422 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 16,033 F1 · kind: Reflects a grant of restricted stock units that vests on May 11, 2022. Read SEC document |
| April 01, 2022 Filed Apr 5, 2022 16:56 UTC |
Carethers JohnDirector
|
GrantCommon Stock | 1,215 | $0.00 | $0.00 |
DisclosureSEC source: 0001722482-22-000080 · wf-form4_164919219540926.xml · nonDerivative · entry 1 Carethers John · CIK 0001874604 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 3,780 F1 · kind: Reflects a grant of restricted stock units that vests on May 11, 2022. Read SEC document |
| April 01, 2022 Filed Apr 5, 2022 16:58 UTC |
Kang LanDirector
|
GrantCommon Stock | 1,215 | $0.00 | $0.00 |
DisclosureSEC source: 0001722482-22-000085 · wf-form4_164919231169381.xml · nonDerivative · entry 1 Kang Lan · CIK 0001863043 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 5,237 F1 · kind: Reflects a grant of restricted stock units that vests on May 11, 2022. Read SEC document |
| April 01, 2022 Filed Apr 5, 2022 16:59 UTC |
Peacock Jonathan MDirector
|
GrantCommon Stock | 1,215 | $0.00 | $0.00 |
DisclosureSEC source: 0001722482-22-000086 · wf-form4_164919233594043.xml · nonDerivative · entry 1 Peacock Jonathan M · CIK 0001500241 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 169,646 F1 · kind: Reflects a grant of restricted stock units that vests on May 11, 2022. Read SEC document |
| April 01, 2022 Filed Apr 5, 2022 21:01 UTC |
Massaro Joseph RDirector
|
GrantCommon Stock | 1,215 | $0.00 | $0.00 |
DisclosureSEC source: 0001722482-22-000089 · wf-form4_164919245582167.xml · nonDerivative · entry 1 Massaro Joseph R · CIK 0001380017 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,960 F1 · kind: Reflects a grant of restricted stock units that vests on May 11, 2022. Read SEC document |
| April 01, 2022 Filed Apr 5, 2022 20:57 UTC |
SEVERINO MICHAELDirector
|
GrantCommon Stock | 1,215 | $0.00 | $0.00 |
DisclosureSEC source: 0001722482-22-000081 · wf-form4_164919221986621.xml · nonDerivative · entry 1 SEVERINO MICHAEL · CIK 0001609447 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 18,473 F1 · kind: Reflects a grant of restricted stock units that vests on May 11, 2022. Read SEC document |
| April 01, 2022 Filed Apr 5, 2022 18:34 UTC |
Holt Matthew S.Director
|
GrantCommon Stock | 1,215 | $0.00 | $0.00 |
DisclosureSEC source: 0001722482-22-000090 · wf-form4_164919802517660.xml · nonDerivative · entry 1 Holt Matthew S. · CIK 0001631836 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,215 F1 · kind: Reflects a grant of restricted stock units that vests on May 11, 2022. Read SEC document |
| April 01, 2022 Filed Apr 5, 2022 20:59 UTC |
Shaw ChristiDirector
|
GrantCommon Stock | 1,215 | $0.00 | $0.00 |
DisclosureSEC source: 0001722482-22-000087 · wf-form4_164919237101467.xml · nonDerivative · entry 1 Shaw Christi · CIK 0001702473 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 19,770 F1 · kind: Reflects a grant of restricted stock units that vests on May 11, 2022. Read SEC document |
| April 01, 2022 Filed Apr 5, 2022 21:00 UTC |
Andres JuanDirector
|
GrantCommon Stock | 1,215 | $0.00 | $0.00 |
DisclosureSEC source: 0001722482-22-000088 · wf-form4_164919239470715.xml · nonDerivative · entry 1 Andres Juan · CIK 0001760670 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 23,402 F1 · kind: Reflects a grant of restricted stock units that vests on May 11, 2022. Read SEC document |
| April 01, 2022 Filed Apr 5, 2022 20:57 UTC |
Murthy MalaDirector
|
GrantCommon Stock | 1,215 | $0.00 | $0.00 |
DisclosureSEC source: 0001722482-22-000083 · wf-form4_164919225869636.xml · nonDerivative · entry 1 Murthy Mala · CIK 0001780955 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 2,131 F1 · kind: Reflects a grant of restricted stock units that vests on May 11, 2022. Read SEC document |
| March 01, 2022 Filed Mar 2, 2022 22:07 UTC |
Brophy GerardEVP, Biopharma Production
|
SaleCommon Stock | 2,027 | $34.47 | $69,870.69 |
DisclosureSEC source: 0001722482-22-000067 · wf-form4_164625880570239.xml · nonDerivative · entry 1 Brophy Gerard · CIK 0001776107 · EVP, Biopharma Production 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 136,221 F1 · kind: The sale reported on this Form 4 was effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person. Read SEC document |
| February 25, 2022 Filed Feb 25, 2022 21:27 UTC |
Couturier ChristopheEVP, AMEA
|
Tax withholdingCommon Stock | 467 | $35.39 | $16,527.13 |
DisclosureSEC source: 0001722482-22-000059 · wf-form4_164584246004889.xml · nonDerivative · entry 2 Couturier Christophe · CIK 0001684076 · EVP, AMEA 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 115,128 F2 · kind: Represents the number of shares withheld by the Issuer to cover tax withholding obligations in connection with the vesting of RSUs. Read SEC document |
| February 25, 2022 Filed Feb 26, 2022 02:34 UTC |
Szlosek Thomas AEVP & CFO
|
Tax withholdingCommon Stock | 2,043 | $35.39 | $72,301.77 |
DisclosureSEC source: 0001722482-22-000063 · wf-form4_164584285096084.xml · nonDerivative · entry 2 Szlosek Thomas A · CIK 0001293167 · EVP & CFO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 252,746 F2 · kind: Represents the number of shares withheld by the Issuer to cover tax withholding obligations in connection with the vesting of RSU's. Read SEC document |
| February 25, 2022 Filed Feb 26, 2022 02:36 UTC |
Vanderhaegen FredericEVP, Americas & Europe
|
Tax withholdingCommon Stock | 216 | $35.39 | $7,644.24 |
DisclosureSEC source: 0001722482-22-000065 · wf-form4_164584298246263.xml · nonDerivative · entry 2 Vanderhaegen Frederic · CIK 0001776162 · EVP, Americas & Europe 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 167,974 F2 · kind: Represents the number of shares withheld by the Issuer to cover tax withholding obligations in connection with the vesting of RSU's. Read SEC document |
| February 25, 2022 Filed Feb 26, 2022 02:32 UTC |
Brophy GerardEVP, Biopharma Production
|
Tax withholdingCommon Stock | 2,043 | $35.39 | $72,301.77 |
DisclosureSEC source: 0001722482-22-000061 · wf-form4_164584265312525.xml · nonDerivative · entry 3 Brophy Gerard · CIK 0001776107 · EVP, Biopharma Production 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 138,248 F4 · kind: Represents the number of shares withheld by the Issuer to cover tax withholding obligations in connection with the vesting of RSU's. Read SEC document |
Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.